Aug 18, 2021
I'm joined today by Biostrap's Chief Science Officer,
Kevin Longoria, and the Director of Research here at NeuFit, Dr.
Ramona von Leden, to talk about the results from our first
During our 6 week study, we used Biostrap's clinically
validated biometric device to measure the effect of Neubie sessions
on the autonomic nervous system of participants. Some of the
metrics we tracked were heart rate variability (HRV) and resting
heart rate (RHR), two major markers for overall nervous system
health. Overall, those metrics improved as a side effect of
"typical" sessions with the Neubie and without any direct
stimulation of the parasympathetic nervous system (i.e., no vagus
nerve stimulation, not using our "Master Reset" technique, etc.).
We do a deep dive into what happened during the study and discuss
some of the implications.